Journal of Clinical Monitoring and Computing· 2026Q2
Anesteziğin analjezik bileşeninin bir ölçüsü olarak temaslı ısı uyarılmış potansiyeller – bir hasta çalışması
Contact heat evoked potentials as a measure of the analgesic component of anesthesia – a patient study
- 0atıf
- Q2SCImago
- 2026yıl
Kısa özet
Temaslı ısı uyarılmış potansiyeller (CHEP'ler), hastanın bildirdiği ağrı (VAS) ile korelasyon göstermemesi ve propofol kaynaklı yanıt kaybı sonrası saptanamaması nedeniyle, genel anesteziğin analjezik bileşenini doğrudan ölçmek için uygun değildir.
Yapay zekâ ile başlık ve abstract'tan üretildi; tam metin okunmaz.
Özet (abstract)
Abstract To assess the applicability of contact heat evoked potentials (CHEPs) as a direct measure of analgesia, we analyzed the following endpoints. (1) Correlation between remifentanil-induced changes in VAS and CHEP amplitudes. (2) Correlation between CHEP amplitude reduction and remifentanil infusion rate. Furthermore, we investigated the sedative effects of remifentanil and the effect of propofol-induced loss of responsiveness (PI-LOR) on CHEPs. After determination of the individual pain threshold (visual analog scale (VAS) of 10), 120 adult ASA physical status I or II patients randomly received remifentanil in one of four predefined infusion rates (0.05, 0.1, 0.2, or 0.4 $$\upmu$$ g/kg/min). After equilibration, a heat stimulus 20% above the individual pain threshold was applied to the volar forearm. Eventually, propofol was infused until LOR, and the heat stimulus was applied again. CHEPs, VAS, and the Observer’s Assessment of Alertness/Sedation (OAA/S) scale, as well as middle latency auditory evoked potentials (MLAEPs), were assessed. A total of 119 patients were included in the analysis. CHEP amplitudes could not be detected for all patients at all times. Remifentanil dosage and VAS showed a strong inverse correlation (r=-0.46; p<0.001). We also detected a correlation between remifentanil dosage and CHEP amplitudes (r=0.29; p=0.003) but not between VAS and CHEPs (r=-0.17; p=0.868). Both the OAA/S score and MLAEPs indicated a correlation between remifentanil dosage and degree of sedation. After PI-LOR, CHEPs were no longer detectable. The exact mechanism for the detected CHEP reduction remains to be determined. CHEPs monitoring appears unsuitable for direct assessment of the analgesic component of general anesthesia. Trial registration: German Clinical Trials Register ID DRKS00003300, Oct 24, 2011.
Yazarların özeti; kaynağından alınmıştır. Journal of Clinical Monitoring and Computing, 2026 · DOI ↗
Devamı Pofolia uygulamasında
Çıkarımlar, ana noktalar ve makaleye soru sorma; ilgi alanına göre her gün yeni özetler. Ücretsiz.
Web'de giriş yaparak açAlan: Anesteziyoloji ve Ağrı Tıbbı
Anesthesiology and Pain MedicineMedicine